VincentElliottChowMD

PubMed

• 2 citations
  A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar
  Walter Reinisch, Stanley N. Cohen, Monica Ramchandani, M. Khraishi, Jennifer Liu, Vincent Chow, Janet Franklin, Jean-Frederic Colombel> ;Advances in Therapy. 2021 Nov 10
• 3 citations
  A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and...
  Vladimir Hanes, Vincent Chow, Tina Stewart, Adeep Puri> ;Cancer Chemotherapy and Pharmacology. 2021 Aug 5
• 3 citations
  Non-clinical similarity of biosimilar ABP 798 with rituximab reference product.
  Helen J. McBride, Shea Jassem, Vincent Chow, Palanisamy Kanakaraj, Herve Lebrec, Scott Kuhns, John Ferbas, Min Wong, Theingi M. Thway> ;Biologicals. 2021 Jul 1
• 2 citations
  Use of nonclinical toxicity studies to support biosimilar antibody development.
  Lauren Mihalcik, Vincent Chow, Monica Ramchandani, Beth Hinkle, Helen J. McBride, Herve Lebrec> ;Regulatory Toxicology and Pharmacology. 2021 Mar 1
• 10 citations
  A Randomized, Double-Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moder...
  Gerd R Burmester, David Chien, Vincent Chow, Melissa A. Gessner, Jean Pan, Stanley N. Cohen> ;Clinical Pharmacology in Drug Development. 2020 Nov 1
• 14 citations
  A randomized, double‐blind, single‐dose, three‐arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris®) in healthy male s...
  Vincent Chow, Jean Pan, David Chien, Daniel T. Mytych, Vladimir Hanes> ;European Journal of Haematology. 2020 Mar 20
• 10 citations
  Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
  Shea Jassem, Wei Wang, Heather Sweet, Raffi Manoukian, Vincent Chow, Palanisamy Kanakaraj, Katariina M. Hutterer, Scott Kuhns, Ian Foltz, Qing Chen, John Ferbas, Helen...> ;Pharmaceutical Research. 2019 Nov 6
• 6 citations
  Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single-Blind, Single-Dose, Parallel-Group Study in Healthy Subje...
  Vincent Chow, MyungShin Oh, Melissa A. Gessner, Gary Fanjiang> ;Clinical Pharmacology in Drug Development. 2019 Oct 19
• 21 citations
  A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
  Richard Markus, Helen J. McBride, Monica Ramchandani, Vincent Chow, Jennifer Liu, Dan Mytych, Gary Fanjiang> ;Advances in Therapy. 2019 Jun 10
• 14 citations
  A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects
  Vladimir Hanes, Vincent Chow, Zhiying Pan, Richard Markus> ;Cancer Chemotherapy and Pharmacology. 2018 Sep 29
• 26 citations
  A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.
  Michael A. Carducci, Montaser Shaheen, Ben Markman, Sara A. Hurvitz, Daruka Mahadevan, Dusan Kotasek, Oscar B. Goodman, Erik Rasmussen, Vincent Chow, Gloria Juan, Greg...> ;Investigational New Drugs. 2018 Jul 7
• Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men.
  Markus, R.,Chow, V.,Pan, Z.,Hanes, V.> ;Cancer Chemother. Pharmacol.. 2017 Nov 22
• 25 citations
  A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.
  Hagop M. Kantarjian, Michael W. Schuster, Nitin Jain, Anjali S. Advani, Elias Jabbour, Erick Gamelin, Erik Rasmussen, Gloria Juan, Abraham Anderson, Vincent Chow, Greg...> ;American Journal of Hematology. 2017 Jul 1
• 59 citations
  A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab
  Primal Kaur, Vincent Chow, N Zhang, Michael Moxness, Arunan Kaliyaperumal, Richard Markus> ;Annals of the Rheumatic Diseases. 2017 Mar 1
• 34 citations
  A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects.
  Vladimir Hanes, Vincent Chow, N Zhang, Richard Markus> ;Cancer Chemotherapy and Pharmacology. 2017 Mar 24
• 13 citations
  Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility
  Chung John Inn, Fernando Alvarez-Nunez, Vincent Chow, Dominick Daurio, John A. Davis, Michael G. Dodds, Maurice Emery, Kevin Litwiler, Anne Paccaly, Joanna Z. Peng, Br...> ;Journal of Pharmaceutical Sciences. 2015 Apr 1
• 6 citations
  The use of pharmacometrics to optimize biosimilar development.
  Michael G. Dodds, Vincent Chow, Richard Markus, Juan Jose Perez-Ruixo, Danny D. Shen, Megan A. Gibbs> ;Journal of Pharmaceutical Sciences. 2013 Nov 1
• 32 citations
  Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment
  Stanley Cohen, Samuel H. Zwillich, Vincent Chow, Robert R. LaBadie, Bethanie Wilkinson> ;British Journal of Clinical Pharmacology. 2010 Feb 1
• 55 citations
  Endoprosthetic proximal femur replacement: Metastatic versus primary tumors☆
  Benjamin K. Potter, Vincent E. Chow, Sheila C. Adams, G. Douglas Letson, H. Thomas Temple> ;Surgical Oncology. 2009 Dec 1
• Join now to see all